info@synchemia.com | sales@synchemia.com 
9766925136 
Brimonidine Nitroso Impurity 2
Specifications
Product name
Brimonidine Nitroso Impurity 2
SRC CAT No
SRC-N014466
CAS No
NA
Mol.F.
C11H9BrN6O
Mol.Wt.
321.13 g/mol
Related CAS No.
NA
Inv Status
CUSTOM SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brimonidine is used to relieve redness in the eyes caused by minor eye irritations (such as smog, swimming, dust, or smoke).Brimonidine Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brimonidine Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Bromoquinoxalin-6-yl)-N-(4,5-dihydro-1H-imidazol-2-yl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brimonidine Nitroso Impurity 2 . We supply Brimonidine Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
N-Nitroso Atipamezole
| CAT No | SRC-N0142419 |
| CAS No | NA |
| Mol.F. | C14H15N3O |
| Mol.Wt. | 241.29 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atomoxetine EP Impurity B | N-Nitroso Atomoxetine S-Isomer
| CAT No | SRC-N0142420 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atomoxetine EP Impurity A (oxalate salt)
| CAT No | SRC-N0142421 |
| CAS No | NA |
| Mol.F. | C16H18N2O2 : C2H2O4 |
| Mol.Wt. | 270.3 : 90.0 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atomoxetine EP Impurity C | N-Nitroso Atomoxetine USP Related Compound C ; N-Nitroso p-Methyl Atomoxetine
| CAT No | SRC-N0142422 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | In Stock |
N-Nitroso Atomoxetine EP Impurity D |Atomoxetine USP Related Compound B ; m-Methyl Atomoxetine HCl
| CAT No | SRC-N0142423 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 g/mol |
| INV STATUS | In Stock |
N-Nitroso Atomoxetine EP Impurity F
| CAT No | SRC-N0142424 |
| CAS No | NA |
| Mol.F. | C17H19FN2O2 |
| Mol.Wt. | 302.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atomoxetine EP Impurity G
| CAT No | SRC-N0142425 |
| CAS No | NA |
| Mol.F. | C27H33N3O3 |
| Mol.Wt. | 447.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N,N-Dinitroso Atomoxetine Impurity G
| CAT No | SRC-N0142426 |
| CAS No | NA |
| Mol.F. | C27H32N4O4 |
| Mol.Wt. | 476.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atomoxetine Impurity H
| CAT No | SRC-N0142427 |
| CAS No | NA |
| Mol.F. | C10H14N2O2 |
| Mol.Wt. | 194.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atrazine A
| CAT No | SRC-N0142428 |
| CAS No | NA |
| Mol.F. | C8H13ClN6O |
| Mol.Wt. | 244.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atrazine C
| CAT No | SRC-N0142429 |
| CAS No | NA |
| Mol.F. | C8H12ClN7O2 |
| Mol.Wt. | 273.68 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Atrazine Impurity 1
| CAT No | SRC-N0142430 |
| CAS No | NA |
| Mol.F. | C7H11ClN6O |
| Mol.Wt. | 230.66 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso N-Desmethyl Galantamine | N-Nitroso Galantamine EP Impurity E
| CAT No | SRC-N0142431 |
| CAS No | NA |
| Mol.F. | C16H18N2O4 |
| Mol.Wt. | 302.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Bimatoprost
| CAT No | SRC-N0142432 |
| CAS No | NA |
| Mol.F. | C25H36N2O5 |
| Mol.Wt. | 444.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
Dibenzyran N-nitroso-impurity A
| CAT No | SRC-N0142433 |
| CAS No | NA |
| Mol.F. | C11H16N2O3 |
| Mol.Wt. | 224.26 g/mol |
| INV STATUS | In Stock |
Dibenzyran N-nitroso-impurity B
| CAT No | SRC-N0142434 |
| CAS No | NA |
| Mol.F. | C16H18N2O2 |
| Mol.Wt. | 270.33 g/mol |
| INV STATUS | In Stock |
